The Importance of Knowing the Local Epidemiology When a Patient With Cirrhosis Acquires a Bacterial Infection
Sebastián Marciano, Marcelo Valverde, Melisa Dirchwolf, María Nelly Gutierrez‐Acevedo, Adrián Gadano – 22 September 2020
Particularities of Autoimmune Hepatitis in Latin America
Debora Terrabuio, Gilda Porta, Eduardo Cançado – 22 September 2020
Hepatitis B Virus and Delta Infection: Special Considerations in the Indigenous and Isolated Riverside Populations in the Amazon Region
César Cabezas, Wornei Braga – 22 September 2020
Are We Really Taking Care of Alcohol‐Related Liver Disease in Latin America?
Juan Pablo Arab, Ramon Bataller, Juan Pablo Roblero – 22 September 2020
DNA Methylation of Cannabinoid Receptor Interacting Protein 1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin‐Dependent Pyruvate Kinase M2 Ubiquitination
Diyu Chen, Hao Wu, Xiaode Feng, Yunhao Chen, Zhen Lv, Vishnu Goutham Kota, Junru Chen, Wenxuan Wu, Yuejie Lu, Hua Liu, Yanpeng Zhang, Shusen Zheng, Jian Wu – 21 September 2020
Consequences of Extended Spectrum Beta‐Lactamase–Producing Enterobacteriaceae and Methicillin‐Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients
Bianca Magro, Alessandra Mazzola, Mona Munteanu, Claire Goumard, Valerie Martinez, Denis Bernard, Olivier Scatton, Salvatore Battaglia, Ciro Celsa, Calogero Cammà, Filomena Conti – 21 September 2020 – Infections in patients with cirrhosis are associated with liver‐related complications (LRCs), especially in patients awaiting liver transplantation (LT). The aim of this study was to evaluate the impact of methicillin‐resistant Staphylococcus aureus (MRSA) and extended spectrum beta‐lactamase colonization on infections and LRCs for patients on the wait list and on infections after LT.
Successful Auxiliary Liver Transplant Followed by Hematopoietic Stem Cell Transplantation in X‐Linked Lymphoproliferative Disease Type 1
Marie‐Eve Chartier, Maesha Deheragoda, Michael Gattens, Anil Dhawan, Nigel Heaton, Claire Booth, Nedim Hadžić – 19 September 2020
LiverLearning®: 2020 Webinar: Current and Future Disease Burden of HBV: Global and Regional Perspectives
In this on-demand webinar, representative speakers from Africa including North and Sub-Saharan Africa (Mark W. Sonderup, South Africa), East Asia (Jidong Jia, China), West and South Asia (Shiv K. Sarin, India), Europe including Western and Eastern Europe (George V. Papatheodoridis, Greece), North America (Carla Coffin, Canada) and South/Central America (Adrian Gadano) will each talk on HBV disease burden and primary challenges in their respective regions. They will present the current status and predictions for the next decade.
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis
Mark R. Deneau, Cara Mack, Douglas Mogul, Emily R. Perito, Pamela L. Valentino, Achiya Z. Amir, Matthew DiGuglielmo, Laura G. Draijer, Wael El‐Matary, Katryn N. Furuya, Nitika Gupta, Jessica T. Hochberg, Simon Horslen, M. Kyle Jensen, Maureen M. Jonas, Nanda Kerkar, Bart G.P. Koot, Trevor J. Laborda, Christine K. Lee, Kathleen M. Loomes, Mercedes Martinez, Alexander Miethke, Tamir Miloh, Saeed Mohammad, Nadia Ovchinsky, Girish Rao, Amanda Ricciuto, Pushpa Sathya, Kathleen B. Schwarz, Uzma Shah, Ruchi Singh, Bernadette Vitola, Andréanne Zizzo, Stephen L. Guthery – 18 September 2020
Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases
Monika Sarkar, Carla W. Brady, Jaquelyn Fleckenstein, Kimberly A. Forde, Vandana Khungar, Jean P. Molleston, Yalda Afshar, Norah A. Terrault – 18 September 2020